My Vape Order, Inc. (MVO) today received the much-anticipated Acceptance letter from U.S. Food and Drug Administration (FDA) for its bundled AIR FACTORY® Premarket Tobacco Application (PMTA). Receipt of FDA’s Acceptance letter confirms that the AIR FACTORY® PMTA meets the statutory and regulatory requirements for a PMTA submission and signals that the PMTA is now in FDA’s “Filing Review,” or preliminary scientific review, phase.
MVO looks forward to working with FDA on its review of the AIR FACTORY® PMTA, which covers a suite of 72 AIR FACTORY® products, including both freebase and salt nicotine formulations in a variety of nicotine strengths tailored to meet the needs of our AIR FACTORY® consumers. The PMTA is supported by robust scientific data, including independently-conducted toxicological risk assessment data for the submitted products, and thorough research establishing the products to be appropriate for the protection of public health. MVO is committed to working with FDA through the entire PMTA review process as expeditiously as possible.
We will continue to provide AIR FACTORY® PMTA and product updates at www.airfactoryeliquid.com. Stay tuned for future updates!
Kyle Godfrey, CEO